HYBIO(SZ:300199) Xin Lang Cai Jing·2025-08-22 01:11Group 1 - Han Yu Pharmaceutical (300199.SZ) released its semi-annual report for 2025 on August 22, 2025 [1] - As of August 21, 2025, seven institutional investors disclosed holdings in Han Yu Pharmaceutical A-shares, totaling 44.3541 million shares, which accounts for 5.02% of the company's total share capital [1] - The institutional investors include Shenzhen High-tech Investment Group Co., Ltd., Hong Kong Central Clearing Limited, and others, with a total institutional holding ratio decreasing by 1.61 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two public funds reduced their holdings compared to the previous quarter, including Bosera CSI Taogold Big Data 100 A and China Merchants Stable Growth Mixed A, with a slight decrease in holding ratio [1] - One insurance fund increased its holdings, specifically Fude Property Insurance Co., Ltd. - proprietary funds, with an increase of 0.1% [1] - Foreign investment sentiment showed a decrease in holdings from one foreign fund, Hong Kong Central Clearing Limited, with a slight decline in holding ratio compared to the previous quarter [1]